home / stock / cotqf / cotqf quote
Last: | $0.0001 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0001 |
Close: | $0.0001 |
High: | $0.0001 |
Low: | $0.0001 |
Volume: | 6,500 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0001 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 6,500 | 11-15-2022 |
$0.0005 | $0.0005 | $0.0005 | $0.0005 | $0.0005 | 22,776 | 09-27-2021 |
$0.0004 | $0.0004 | $0.0004 | $0.0004 | $0.0004 | 41,667 | 09-16-2021 |
$0.007 | $0.007 | $0.007 | $0.007 | $0.007 | 111 | 09-02-2021 |
$0.0055 | $0.0055 | $0.0055 | $0.0055 | $0.0055 | 100 | 08-27-2021 |
$0.11 | $0.11 | $0.11 | $0.11 | $0.11 | 2,025 | 08-26-2021 |
$0.1028 | $0.10275 | $0.1028 | $0.1028 | $0.1028 | 100 | 08-18-2021 |
$0.0701 | $0.0701 | $0.0701 | $0.0701 | $0.0701 | 600 | 08-12-2021 |
$0.1547 | $0.15465 | $0.1547 | $0.1547 | $0.1547 | 100 | 08-05-2021 |
$0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 250 | 08-04-2021 |
$0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 404 | 08-03-2021 |
$0.1093 | $0.0186 | $0.1093 | $0.1093 | $0.0186 | 300 | 08-02-2021 |
$0.023 | $0.023 | $0.023 | $0.023 | $0.023 | 100 | 07-29-2021 |
$0.0353 | $0.0353 | $0.0353 | $0.0353 | $0.0353 | 2,002 | 07-23-2021 |
$0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 100 | 07-20-2021 |
$0.05 | $0.0393 | $0.05 | $0.072 | $0.0393 | 7,660 | 07-16-2021 |
$0.13 | $0.13 | $0.13 | $0.13 | $0.13 | 200 | 07-12-2021 |
$0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 300 | 06-29-2021 |
$0.06 | $0.065 | $0.06 | $0.065 | $0.06 | 4,000 | 06-25-2021 |
$0.13 | $0.13 | $0.13 | $0.13 | $0.13 | 100 | 06-24-2021 |
News, Short Squeeze, Breakout and More Instantly...
Cotinga Pharmaceuticals Inc Company Name:
COTQF Stock Symbol:
OTCMKTS Market:
TORONTO and BOSTON, July 18, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”) , a clinical-stage pharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer, announced today t...
TORONTO and BOSTON, June 27, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”) , a clinical-stage pharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer, announced today t...
TORONTO and BOSTON, June 05, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”) , a clinical-stage pharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer, announced today t...